 | |  |
Drugs Pulled on Risk to Infants
Johnson & Johnson’s Pediacare Infant Drops and Tylenol Concentrated Infant Drops were voluntarily pulled due to government concerns about health risks for infants. Wyeth’s Dimetapp Decongestant Infant Drops, Novartis’ Triaminic Infant and Toddler Thin Strips and Prestige Brands’ Little Colds Decongestant Plus Cough were also pulled. J&J rose 0.2% to 65.95, Wyeth fell 0.8% to 45.78 and Prestige dipped 0.3% to 11.13.
Wyeth was hit by a $134.5 million judgment in a lawsuit filed by three women who claimed the company’s hormone replacement drugs caused their breast cancer. A Nev. Jury will next decide on punitive damages. The company also faces about 5,300 similar suits.
Infinite Health Resources does not at any point, for any circumstances suggest that you do not follow or stop medical advice of your physician. We do not advocate any drugs that has not been prescribed by your physician, nor suggest that we are medical doctors nor are we giving medical advice. Infinite Health Resources is here purely as a resource. |
 | |  |
